|
⚲
|
| Keyboard |
| Nardo Christopher J
✚
|
|
|---|---|
| CIK # | 0001870247 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001870247] | |
| 4 | [0001870247] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Dermata Therapeutics Inc | |
| Nardo Christopher J |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Dermata Therapeutics Inc DRMA
Stock Option (right to buy) · derivative
|
2026-01-02 | Grant | 18,000 | $0.00 | |
|
Dermata Therapeutics Inc DRMA
Stock Option (right to buy) · derivative
|
2025-01-13 | Grant | 20,000 | $0.00 | |
|
Dermata Therapeutics Inc DRMA
Stock Option (right to buy · derivative
|
2024-01-04 | Grant | 50,000 | $0.00 | |
|
Dermata Therapeutics Inc DRMA
Stock Option (right to buy) · derivative
|
2023-01-03 | Grant | 100,000 | $0.00 | |
|
Dermata Therapeutics Inc DRMA
Stock Option (right to buy) · derivative
|
2022-07-01 | Grant | 30,000 | $0.00 | |
|
Dermata Therapeutics Inc DRMA
Stock Option (right to buy) · derivative
|
2022-01-03 | Grant | 30,000 | $0.00 | |
|
Dermata Therapeutics Inc DRMA
Common Stock
|
2021-08-17 | Conversion | 2,439 | ||
|
Dermata Therapeutics Inc DRMA
Series 1 Preferred Stock · derivative
|
2021-08-17 | Conversion | 50,000 | $0.00 |